These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15845728)

  • 1. Skin sensitivity to rocuronium and vecuronium: prick-tests are not intradermal test.
    Dhonneur G
    Anesth Analg; 2005 May; 100(5):1539-1540. PubMed ID: 15845728
    [No Abstract]   [Full Text] [Related]  

  • 2. Prick testing for neuromuscular blocking drugs.
    Dhonneur G
    Anesth Analg; 2004 Dec; 99(6):1880-1881. PubMed ID: 15562106
    [No Abstract]   [Full Text] [Related]  

  • 3. Skin sensitivity to rocuronium and vecuronium: a randomized controlled prick-testing study in healthy volunteers.
    Dhonneur G; Combes X; Chassard D; Merle JC
    Anesth Analg; 2004 Apr; 98(4):986-989. PubMed ID: 15041585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vecuronium, like rocuronium, causes pain on injection.
    Ti LK; Dhara SS
    Br J Anaesth; 1998 Sep; 81(3):487. PubMed ID: 9861154
    [No Abstract]   [Full Text] [Related]  

  • 5. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of food and drug administration reporting of adverse events.
    Bhananker SM; O'Donnell JT; Salemi JR; Bishop MJ
    Anesth Analg; 2005 Sep; 101(3):819-822. PubMed ID: 16115997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe anaphylactic reactions after administration of rocuronium].
    Barthelet Y; Ryckwaert Y; Plasse C; Bonnet-Boyer MC; d'Athis F
    Ann Fr Anesth Reanim; 1999 Oct; 18(8):896-900. PubMed ID: 10575503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergy to rocuronium: from clinical suspicion to correct diagnosis.
    Leysen J; Bridts CH; De Clerck LS; Vercauteren M; Lambert J; Weyler JJ; Stevens WJ; Ebo DG
    Allergy; 2011 Aug; 66(8):1014-9. PubMed ID: 21375539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: determination of drug concentration thresholds using a dilution titration technique.
    Berg CM; Heier T; Wilhelmsen V; Florvaag E
    Acta Anaesthesiol Scand; 2003 May; 47(5):576-82. PubMed ID: 12699516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection pain of rocuronium and vecuronium is evoked by direct activation of nociceptive nerve endings.
    Blunk JA; Seifert F; Schmelz M; Reeh PW; Koppert W
    Eur J Anaesthesiol; 2003 Mar; 20(3):245-53. PubMed ID: 12650497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction.
    Pedersen AF; Green S; Rose MA
    Anaesth Intensive Care; 2012 Nov; 40(6):1053-5. PubMed ID: 23194216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allergy investigations after two cases of adverse reactions to a neuromuscular blocking agent and management for subsequent general anaesthesia].
    Louvier N; Chomel A; Collet E; Juniot A; Pillet M
    Ann Fr Anesth Reanim; 2003 Jan; 22(1):54-7. PubMed ID: 12738022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugammadex approved to reverse NMBA effects.
    Thompson CA
    Am J Health Syst Pharm; 2016 Feb; 73(3):100. PubMed ID: 26796899
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaphylactic reaction to rocuronium bromide.
    Yee R; Fernandez JA
    Anaesth Intensive Care; 1996 Oct; 24(5):601-4. PubMed ID: 8909675
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of rocuronium for controlled intubation with paralytics in the pediatric emergency department.
    Mendez DR; Goto CS; Abramo TJ; Wiebe RA
    Pediatr Emerg Care; 2001 Aug; 17(4):233-6. PubMed ID: 11493818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide.
    Ebo DG; Bridts CH; Hagendorens MM; Mertens CH; De Clerck LS; Stevens WJ
    Allergy; 2006 Aug; 61(8):935-9. PubMed ID: 16867045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex and rocuronium-induced anaphylaxis.
    Takazawa T; Mitsuhata H; Mertes PM
    J Anesth; 2016 Apr; 30(2):290-7. PubMed ID: 26646837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-IgE-Dependent Hypersensitivity to Rocuronium Reversed by Sugammadex: Report of Three Cases and Hypothesis on the Underlying Mechanism.
    Spoerl D; D'Incau S; Roux-Lombard P; Harr T; Czarnetzki C
    Int Arch Allergy Immunol; 2016; 169(4):256-62. PubMed ID: 27240836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Apropos of drug allergy].
    Sabbah A
    Allerg Immunol (Paris); 1996 Sep; 28(7):230, 233. PubMed ID: 8983238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of priming with vecuronium and rocuronium on young and elderly patients.
    Aziz L; Jahangir SM; Choudhury SN; Rahman K; Ohta Y; Hirakawa M
    Anesth Analg; 1997 Sep; 85(3):663-6. PubMed ID: 9296427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.